MaltSci 麦伴科研

Appearance

Popular Reports / aging-biology

This report is written by MaltSci based on the latest literature and research findings

How do longevity interventions extend lifespan? ​

Abstract ​

The quest for longevity has captured human interest for centuries, and recent advancements in biomedical research have illuminated potential interventions to extend lifespan and healthspan. Understanding the biological mechanisms underlying aging—such as cellular senescence, oxidative stress, and chronic inflammation—has become increasingly vital as life expectancy rises globally. This review synthesizes current findings on various longevity interventions, including caloric restriction, pharmacological agents, genetic modifications, and lifestyle changes. Caloric restriction has consistently demonstrated its ability to extend lifespan across multiple species by reducing oxidative stress and enhancing metabolic health. Pharmacological agents like rapamycin and metformin show promise in modulating aging pathways, with rapamycin effectively mimicking dietary restriction effects. Genetic interventions, particularly through CRISPR technology, offer targeted strategies for promoting longevity. Lifestyle modifications, including diet and exercise, play a crucial role in improving healthspan and combating age-related diseases. Furthermore, ethical considerations regarding equitable access to these interventions are paramount, as disparities could exacerbate existing healthcare inequalities. As research progresses, the integration of diverse interventions and personalized medicine approaches will be essential for optimizing longevity outcomes, ultimately contributing to healthier aging and improved quality of life for aging populations.

Outline ​

This report will discuss the following questions.

  • 1 Introduction
  • 2 Mechanisms of Aging
    • 2.1 Cellular Senescence
    • 2.2 Oxidative Stress
    • 2.3 Inflammation
  • 3 Longevity Interventions
    • 3.1 Caloric Restriction
    • 3.2 Pharmacological Agents (e.g., Rapamycin, Metformin)
    • 3.3 Genetic Modifications (e.g., CRISPR, Gene Therapy)
    • 3.4 Lifestyle Interventions (e.g., Exercise, Diet)
  • 4 Preclinical and Clinical Evidence
    • 4.1 Animal Studies
    • 4.2 Human Clinical Trials
    • 4.3 Comparative Effectiveness of Interventions
  • 5 Ethical and Societal Implications
    • 5.1 Equity in Access to Longevity Interventions
    • 5.2 Impacts on Healthcare Systems
    • 5.3 Philosophical Considerations of Extended Lifespan
  • 6 Future Directions in Longevity Research
    • 6.1 Emerging Technologies
    • 6.2 Personalized Medicine Approaches
    • 6.3 Integration of Interventions for Optimal Outcomes
  • 7 Conclusion

1 Introduction ​

The pursuit of longevity has been a fundamental aspect of human curiosity and scientific inquiry for centuries. As global life expectancy continues to rise, understanding the biological mechanisms that underpin aging has become increasingly important. Recent advancements in biomedical research have illuminated various pathways and interventions that can potentially extend lifespan and healthspan, offering hope for enhancing the quality of life in aging populations. The concept of aging is now recognized as a complex biological process rather than a mere consequence of time, prompting researchers to explore innovative strategies that target the underlying mechanisms of aging, including cellular senescence, oxidative stress, and chronic inflammation[1][2].

The significance of longevity research lies not only in the extension of lifespan but also in the enhancement of healthspan—the period of life spent in good health. The increasing elderly population is associated with a rise in age-related diseases, placing substantial burdens on healthcare systems worldwide[3]. Therefore, interventions that can delay the onset of age-related pathologies while promoting vitality and well-being are of paramount importance. Recent studies have shown that various interventions, including caloric restriction, pharmacological agents, genetic modifications, and lifestyle changes, can modulate the aging process and improve health outcomes[4][5].

Current research has revealed a plethora of longevity interventions, each with distinct mechanisms of action. Caloric restriction, for instance, has been consistently associated with lifespan extension across multiple model organisms, demonstrating effects that may be mediated through pathways such as the mechanistic target of rapamycin (mTOR) and the insulin/IGF-1 signaling pathways[6][7]. Pharmacological agents, including rapamycin and metformin, have also emerged as promising candidates for lifespan extension, showing efficacy in preclinical models and ongoing clinical trials[8][9]. Moreover, advancements in genetic engineering, particularly through CRISPR and gene therapy, offer potential for targeted interventions that could revolutionize our approach to aging[10].

This review will synthesize current findings from both preclinical and clinical studies, exploring the efficacy and safety of various longevity interventions. We will begin by discussing the fundamental mechanisms of aging, including cellular senescence, oxidative stress, and inflammation, which serve as targets for intervention. Following this, we will delve into specific longevity interventions, categorizing them into caloric restriction, pharmacological agents, genetic modifications, and lifestyle changes. We will then evaluate the preclinical and clinical evidence supporting these interventions, highlighting comparative effectiveness and safety profiles. Additionally, we will address the ethical and societal implications of extending lifespan, particularly concerning equitable access to these interventions and their potential impacts on healthcare systems. Finally, we will outline future directions in longevity research, emphasizing the need for integrative approaches that combine multiple interventions for optimal outcomes.

In summary, this report aims to provide a comprehensive overview of the current state of longevity research, exploring the possibilities and challenges of various interventions. By understanding the mechanisms and effects of these interventions, we can contribute to the ongoing dialogue on enhancing healthspan alongside lifespan, ultimately improving the quality of life for aging populations worldwide.

2 Mechanisms of Aging ​

2.1 Cellular Senescence ​

Cellular senescence is increasingly recognized as a pivotal mechanism underlying the aging process and the development of age-related diseases. Interventions targeting cellular senescence offer promising strategies for extending lifespan and healthspan. The fundamental nature of cellular senescence involves irreversible cell cycle arrest, which can be triggered by various stressors, including DNA damage, oxidative stress, and oncogene activation. As senescent cells accumulate, they contribute to a pro-inflammatory environment through the senescence-associated secretory phenotype (SASP), leading to tissue dysfunction and increased susceptibility to age-related disorders [11][12][13].

One primary mechanism through which longevity interventions may extend lifespan is by reducing the burden of senescent cells in tissues. Senolytic therapies, which selectively eliminate senescent cells, have shown potential in preclinical studies to improve health outcomes by alleviating the detrimental effects of SASP. For instance, the combination of dasatinib and quercetin has been demonstrated to effectively clear senescent cells, resulting in improved physical function and extended lifespan in animal models [11][13].

Moreover, lifestyle interventions such as caloric restriction (CR) and exercise also modulate cellular senescence pathways. CR has been associated with reduced cellular senescence and improved resilience against age-related stressors, thus promoting longevity. The protective effects of CR are thought to stem from metabolic reprogramming that enhances cellular stress defenses and promotes longevity [7][14].

In addition to senolytics and lifestyle modifications, emerging therapies known as senomorphics aim to modify the SASP without eliminating senescent cells. By dampening the inflammatory signals associated with senescence, these agents may help mitigate the adverse effects of senescent cells on surrounding tissues, thereby contributing to healthier aging [13].

Furthermore, recent studies have highlighted the interconnectedness of cellular senescence with other aging mechanisms, such as mitochondrial dysfunction and epigenetic changes. Addressing these interrelated pathways may provide a more comprehensive approach to extending healthspan and lifespan [9][15].

In conclusion, longevity interventions that target cellular senescence—through the elimination of senescent cells, modulation of the SASP, and lifestyle changes—represent a promising frontier in aging research. These strategies not only hold the potential to extend lifespan but also to enhance the quality of life by reducing the burden of age-related diseases. Continued research into the mechanisms of cellular senescence and the development of effective therapeutic interventions is crucial for advancing our understanding of healthy aging.

2.2 Oxidative Stress ​

Longevity interventions have been shown to extend lifespan through various mechanisms, with a significant focus on the role of oxidative stress. Research indicates that oxidative stress, characterized by an imbalance between reactive oxygen species (ROS) and antioxidant defenses, is a key factor influencing aging and longevity.

Long-lived species exhibit lower rates of ROS generation and oxidative damage, particularly at the mitochondrial level. This is supported by findings that specific compositional patterns of macromolecules in these species confer intrinsic resistance to oxidative modifications, thereby contributing to their longevity. For instance, a decrease in the degree of fatty acid unsaturation in lipids and a reduction in methionine content in proteins have been associated with enhanced oxidative stress resistance in long-lived animals (Pamplona & Barja, 2011) [16].

Moreover, interventions that disrupt insulin/IGF-1 signaling, which is linked to metabolic regulation, have been shown to activate cytoprotective mechanisms that buffer stress and damage. These mechanisms include detoxification, innate immunity, and oxidative stress response, which are critical in extending lifespan across various species (Shore & Ruvkun, 2013) [17]. Such pathways enhance the organism's ability to withstand oxidative stress, thereby promoting longevity.

Interestingly, some studies challenge the traditional view of oxidative stress as solely detrimental. Evidence suggests that increased ROS levels, induced by certain interventions, can activate endogenous defense mechanisms through a process known as mitohormesis. This phenomenon posits that mild oxidative stress can stimulate protective responses, enhancing stress resistance and ultimately contributing to lifespan extension. For example, caloric restriction or inactivation of antioxidant defenses in yeast has been shown to increase ROS levels, leading to improved longevity via enhanced superoxide dismutase activity (Mesquita et al., 2010) [18].

Furthermore, research highlights the role of environmental factors and lifestyle in modulating oxidative stress responses. Centenarians often exhibit genetic and lifestyle traits that enable them to maintain efficient stress responses, thereby managing ROS levels and promoting healthy aging. This integration of lifestyle factors, such as a diet rich in antioxidants and regular physical activity, alongside genetic predispositions, plays a crucial role in counteracting oxidative stress and enhancing longevity (Dato et al., 2013) [19].

In summary, longevity interventions extend lifespan through a complex interplay of reducing oxidative damage, enhancing stress resistance, and leveraging mild oxidative stress to activate protective pathways. These mechanisms underscore the multifaceted nature of aging and the potential for targeted interventions to promote health and longevity.

2.3 Inflammation ​

Longevity interventions have been shown to extend lifespan through various mechanisms, with inflammation playing a crucial role in the aging process. The phenomenon known as "inflammaging," which refers to the chronic low-grade inflammation that often develops with age, has significant implications for healthspan and longevity. Inflammaging is characterized by elevated levels of pro-inflammatory cytokines, such as IL-6 and TNF-α, which are associated with an increased risk of chronic diseases and functional decline in older adults [20].

Interventions targeting inflammation can enhance immunity and potentially improve health outcomes in the elderly. Strategies that reduce inflammation have been suggested as beneficial for enhancing immune responses during aging. For instance, therapies aimed at lowering chronic inflammation may restore immune function, thereby mitigating some of the adverse effects associated with aging [20].

Moreover, research has indicated that targeting fundamental aging mechanisms, including chronic inflammation, can extend healthspan and lifespan. The geroscience hypothesis posits that by addressing these underlying mechanisms, rather than focusing solely on individual age-related diseases, it is possible to achieve greater health benefits [9]. This approach encompasses various interventions, such as dietary modifications, pharmacological agents, and lifestyle changes that collectively aim to counteract the effects of inflammaging.

Cytokines, while often viewed as detrimental in the context of aging, also play a dual role. Certain cytokines, such as IL-6 and TNF, can promote beneficial processes like macroautophagy and mitochondrial function, which may contribute positively to longevity [21]. This dichotomy underscores the complexity of inflammatory responses in aging, suggesting that while chronic inflammation is harmful, specific inflammatory signals may also facilitate adaptive responses that support longevity.

In summary, longevity interventions extend lifespan by modulating inflammatory pathways and targeting the underlying mechanisms of aging, such as inflammaging. By reducing chronic inflammation and enhancing immune function, these interventions not only improve healthspan but also contribute to a more resilient aging process. Further research is needed to elucidate the specific pathways involved and to develop targeted strategies that optimize these interventions for promoting longevity and health in aging populations [5][22].

3 Longevity Interventions ​

3.1 Caloric Restriction ​

Caloric restriction (CR) has been extensively studied as a potent intervention for extending lifespan across various species, including yeast, rodents, and primates. This dietary approach involves reducing caloric intake without causing malnutrition and has been shown to slow aging processes and increase both mean and maximum lifespan. The underlying mechanisms by which CR extends lifespan are multifaceted and involve a range of biological and metabolic adaptations.

One of the key findings is that CR reduces oxidative stress, which is linked to aging. Studies have shown that caloric restriction leads to decreased oxidative damage to proteins, lipids, and DNA, primarily through a reduction in mitochondrial free radical generation [23]. This reduction in oxidative damage is associated with improved mitochondrial function and enhanced oxidative defense mechanisms [24].

In addition to oxidative stress reduction, CR appears to influence metabolic pathways that regulate aging. For instance, it has been suggested that CR may activate certain signaling pathways, such as the target of rapamycin (TOR) pathway and the circadian clock, which are involved in the regulation of longevity [4]. The interplay between these pathways is complex, and while some mechanisms overlap, others may be distinct and independent, indicating a multifactorial approach to lifespan extension [24].

Moreover, genetic factors play a significant role in how CR impacts lifespan. Research indicates that the genetic background of an organism can modulate the effects of dietary restriction, highlighting the importance of individual variability in response to CR [24]. This variability can influence health outcomes, suggesting that personalized approaches to dietary interventions may be necessary for optimal results.

Recent studies have also explored the effects of intermittent fasting (IF) as an alternative to continuous caloric restriction. IF, which involves cycles of eating and fasting, has been shown to extend lifespan in some animal models, potentially by inducing similar biological responses as CR [25]. For example, a study demonstrated that a 30% caloric restriction combined with circadian alignment of feeding resulted in a significant lifespan extension in mice, independent of body weight [26].

Despite the promising findings in animal models, the translation of these interventions to humans remains a complex challenge. While evidence suggests that CR can increase lifespan by 1-5 years and improve health span in humans, the practical implementation of long-term caloric restriction poses difficulties [27]. Factors such as adherence to dietary changes, quality of life, and potential health risks must be considered [28].

In conclusion, caloric restriction and related dietary interventions extend lifespan through a combination of mechanisms that reduce oxidative stress, modulate metabolic pathways, and potentially activate longevity-related genes. The variability in response due to genetic factors underscores the need for tailored approaches to dietary interventions aimed at enhancing health and longevity in humans.

3.2 Pharmacological Agents (e.g., Rapamycin, Metformin) ​

Longevity interventions, particularly pharmacological agents such as rapamycin and metformin, have been extensively studied for their potential to extend lifespan through various biological mechanisms.

Rapamycin, an inhibitor of the mechanistic target of rapamycin (mTOR), has demonstrated significant effects on lifespan extension across multiple vertebrate species. It promotes autophagy, enhances mitochondrial biogenesis, and reduces inflammation, all of which are critical processes in maintaining cellular health and function. Studies indicate that rapamycin mirrors the effects of dietary restriction (DR), a well-established method for lifespan extension, by promoting a catabolic state that enhances longevity. A meta-analysis comparing the lifespan extension effects of rapamycin and metformin found that while both agents have been associated with increased lifespan, rapamycin produced a significant lifespan extension, whereas metformin's effects were less conclusive across vertebrate models (Ivimey-Cook et al., 2025) [29].

Metformin, primarily known as an antihyperglycemic agent for type 2 diabetes, has also been shown to extend lifespan and delay the onset of age-related diseases in various model organisms. Its mechanisms include the modulation of insulin signaling, reduction of oxidative stress, and activation of AMP-activated protein kinase (AMPK), which in turn inhibits mTOR signaling. This inhibition is critical as mTOR signaling is linked to aging and age-related diseases. Research indicates that metformin can reduce the levels of S-adenosylmethionine (SAM), which may alter histone methylation and contribute to longevity. Additionally, metformin promotes lifespan extension through the v-ATPase-Ragulator lysosomal pathway, coordinating mTORC1 and AMPK activities, which are essential for metabolic regulation (Chen et al., 2017; Xiao et al., 2022) [30][31].

Furthermore, metformin's effects have been linked to its ability to upregulate antioxidant pathways, such as the Nrf2-GPx7 signaling pathway, which is crucial for counteracting cellular aging and promoting healthspan (Fang et al., 2018) [32]. The anti-inflammatory effects of metformin also play a role in its longevity-promoting properties, as inflammation is a significant factor in the aging process.

In conclusion, both rapamycin and metformin extend lifespan through a combination of metabolic regulation, reduction of oxidative stress, promotion of autophagy, and modulation of inflammatory pathways. Their ability to mimic aspects of caloric restriction further emphasizes their potential as therapeutic agents in the pursuit of healthy aging and longevity. Ongoing research continues to elucidate the specific mechanisms by which these pharmacological agents exert their effects, with the hope of translating these findings into clinical applications for human aging.

3.3 Genetic Modifications (e.g., CRISPR, Gene Therapy) ​

Longevity interventions, particularly genetic modifications such as CRISPR and gene therapy, have demonstrated significant potential in extending lifespan across various model organisms. These interventions typically target conserved biological pathways associated with aging, metabolism, and stress response.

CRISPR technology, which allows precise editing of genetic sequences, has emerged as a powerful tool for longevity research. For instance, in a study utilizing CRISPR-based gene editing, researchers delivered CRISPR-Cas9 guide RNAs to disrupt the human SOD1 gene in a mouse model of amyotrophic lateral sclerosis (ALS). This approach not only reduced the levels of mutant SOD1 protein but also significantly extended the lifespan of treated mice by more than 110 days, showcasing the efficacy of targeted genetic interventions in promoting longevity (Chen et al., 2023) [33].

Gene therapy has also been explored as a means to enhance lifespan. Rattan and Singh (2009) noted that genetic interventions could increase longevity by either switching off specific genes or overexpressing genes associated with stress responses and antioxidants. However, the applicability of these genetic modifications in humans remains a challenge due to the complex interplay of genetic and epigenetic factors that govern human growth and development (Rattan & Singh, 2009) [10].

Further insights into genetic modifications have been provided by Tyshkovskiy et al. (2019), who performed RNA sequencing analyses on mice subjected to various longevity interventions. Their findings revealed that many interventions induce similar gene expression changes, particularly in hepatic gene signatures associated with lifespan extension, such as the upregulation of oxidative phosphorylation and drug metabolism pathways. This suggests that there are common genetic mechanisms that can be manipulated to promote longevity (Tyshkovskiy et al., 2019) [34].

Moreover, genetic background plays a crucial role in how organisms respond to these interventions. Mulvey et al. (2014) emphasized that the efficacy of genetic and pharmacological interventions can vary significantly based on the genetic makeup of the individual. Understanding these variations is critical for translating findings from model organisms to human applications (Mulvey et al., 2014) [35].

Overall, the application of genetic modifications for longevity involves targeting specific genes and pathways that regulate aging processes. While promising, the complexity of genetic interactions and the necessity for further research into the long-term effects of such interventions on human health remain pivotal considerations in the field of longevity research.

3.4 Lifestyle Interventions (e.g., Exercise, Diet) ​

Longevity interventions encompass a variety of lifestyle modifications, particularly in the domains of diet and exercise, which have been shown to extend lifespan and improve healthspan across different model organisms, including mice and humans.

Caloric restriction (CR) is one of the most well-studied dietary interventions. It has been shown to extend healthy lifespan in various species, including mice, through mechanisms that include improved metabolic health and reduced incidence of age-related diseases. In a study involving 960 genetically diverse female mice, both caloric restriction (20% and 40%) and intermittent fasting were assessed, revealing that these interventions resulted in lifespan extension proportional to the degree of dietary restriction. However, the effects on health were complex; for instance, while 40% caloric restriction significantly extended lifespan, it also led to loss of lean mass and changes in immune function that could increase susceptibility to infections (Di Francesco et al., 2024) [25].

Another dietary intervention, methionine restriction (MR), has also been linked to lifespan extension. MR delays the onset of age-related diseases and improves metabolic health by altering lipid metabolism and reducing oxidative stress. In models of progeria, MR was shown to extend lifespan and improve health by reversing transcriptomic alterations associated with inflammation and DNA damage (Bárcena et al., 2018) [36].

Exercise is another critical component of longevity interventions. Regular physical activity is associated with numerous health benefits, including enhanced cardiovascular health and metabolic function. A review highlighted that meeting or exceeding the recommended levels of aerobic activity (at least 150 minutes per week) significantly contributes to longevity. Furthermore, combining endurance training with strength training can mitigate muscle loss associated with aging, which is crucial for maintaining functional health in older adults (Pedersen, 2019) [37].

Lifestyle interventions that integrate both diet and exercise have been shown to yield synergistic effects on longevity. A systematic review indicated that interventions combining dietary changes with physical activity not only prevent weight gain but also improve metabolic health markers, thereby reducing the risk of chronic diseases such as diabetes and hypertension (Brown et al., 2009) [38].

Moreover, lifestyle modifications, including a healthy diet and regular physical activity, have been linked to telomere length maintenance, a biomarker of cellular aging. A systematic review found that lifestyle interventions involving diet and exercise led to increased telomere length, suggesting a direct impact on biological aging processes (Buttet et al., 2022) [39].

In conclusion, longevity interventions extend lifespan through a multifaceted approach that includes caloric and dietary restrictions, regular exercise, and the maintenance of metabolic health. These interventions not only enhance lifespan but also improve healthspan, highlighting the importance of a holistic approach to aging.

4 Preclinical and Clinical Evidence ​

4.1 Animal Studies ​

Longevity interventions have been shown to extend lifespan through various mechanisms, as evidenced by numerous animal studies. These interventions include pharmacological, dietary, and genetic modifications that target the biological processes of aging.

One of the most extensively studied interventions is caloric restriction (CR), which has consistently demonstrated its ability to prolong lifespan across a range of species, including rodents and primates. CR not only extends lifespan but also delays the onset of age-related diseases such as cardiovascular disease and diabetes [40]. In studies involving nonhuman primates, CR has produced physiological responses akin to those observed in laboratory rodents, suggesting that the beneficial effects of CR on aging may also apply to longer-lived species [40].

In addition to caloric restriction, other interventions have shown promise in extending lifespan. For instance, reductions in growth hormone signaling have been linked to a lifespan increase of over 50% in mice [6]. Similarly, methionine restriction has been associated with lifespan extension in both rats and mice [6]. These interventions affect metabolic health, mitochondrial function, and stress resistance, all of which play crucial roles in the aging process [6].

Pharmacological interventions, such as the use of resveratrol, rapamycin, and metformin, have also been explored for their longevity-promoting effects. For example, resveratrol has been noted for its potential to mimic the effects of caloric restriction and improve healthspan [41]. Furthermore, studies have identified gene expression signatures associated with lifespan extension across various pharmacological interventions, suggesting a shared biological pathway that could be targeted for therapeutic purposes [34].

Recent research has also focused on the mechanisms underlying longevity interventions. For instance, multi-tissue RNA sequencing across multiple mammalian species has revealed shared longevity signatures, such as downregulated IGF1 signaling and upregulated mitochondrial translation genes [2]. These findings suggest that certain molecular pathways are conserved across species and could be harnessed for developing interventions aimed at extending lifespan in humans.

The impact of longevity interventions is not limited to lifespan extension; they also aim to compress morbidity, thereby improving the quality of life. Interventions that steepen the survival curve are predicted to compress the duration of disability relative to lifespan, thus enhancing healthspan [5]. This is crucial as it indicates that extending life should ideally be accompanied by a better quality of life, with reduced periods of illness and disability.

In summary, longevity interventions extend lifespan through a variety of mechanisms, including caloric restriction, growth hormone signaling reduction, and pharmacological agents targeting specific biological pathways. The ongoing research in animal models provides a foundational understanding that could eventually translate into effective strategies for promoting longevity and healthspan in humans.

4.2 Human Clinical Trials ​

Longevity interventions aim to extend lifespan through various mechanisms that have been explored in both preclinical and clinical settings. These interventions include pharmacological, dietary, and genetic strategies, and the evidence supporting their effectiveness is drawn from studies conducted on model organisms as well as human trials.

In preclinical studies, numerous interventions have demonstrated the potential to extend lifespan. For instance, reduced growth hormone signaling has been shown to increase lifespan in mice by over 50%, while dietary restrictions, such as methionine reduction, have similarly resulted in lifespan extension in both rats and mice (Brown-Borg 2016) [6]. Moreover, a study on cranberry supplementation indicated that it promotes longevity through mechanisms such as reducing oxidative damage, which is a common factor in aging processes (Sun et al. 2014) [42].

The translation of these findings into human clinical trials presents several challenges. Kirkland (2013) emphasizes the necessity for realistic preclinical and clinical trial paradigms that focus on subjects with age-related diseases or frailty, as well as measuring short-term outcomes that are clinically relevant, rather than solely relying on long-term outcomes like healthspan or lifespan (Kirkland 2013) [43]. This is critical because the physiological responses and the underlying mechanisms of aging can differ significantly between model organisms and humans.

Furthermore, the identification of effective longevity interventions for humans requires robust methodologies to assess their impact on aging. Liu et al. (2022) highlight the importance of tracking aging processes in individuals and suggest that wearable devices can be utilized to monitor biological aging rates, which is essential for evaluating the effectiveness of longevity interventions (Liu et al. 2022) [44].

In addition, the concept of longevity clinics is emerging as a potential model for applying these interventions in a clinical setting. These clinics focus on preclinical prevention and utilize biomarkers to assess health status, aiming to extend healthy life rather than merely lifespan (Mironov et al. 2024) [45].

Overall, while substantial progress has been made in understanding how longevity interventions can extend lifespan, the path from bench to bedside is fraught with challenges that require careful consideration of human biology, clinical trial design, and the translation of findings from animal models to human applications. The ultimate goal is to not only extend lifespan but also to compress morbidity, ensuring that individuals can enjoy a healthier life for longer periods.

4.3 Comparative Effectiveness of Interventions ​

Longevity interventions extend lifespan through various mechanisms and strategies that target biological processes associated with aging. A significant body of research has explored the comparative effectiveness of these interventions across different model organisms, including mice, Caenorhabditis elegans, and Drosophila melanogaster.

One of the key findings is that certain interventions can alter the shape of the survival curve, which is a graphical representation of the proportion of individuals surviving at each age. Research by Yang et al. (2025) indicates that interventions like caloric restriction, which extend mean lifespan, do not compress the sickspan (the duration of morbidity) but rather extend it proportionally. Conversely, other interventions that steepen the survival curve may compress the sickspan, thus potentially leading to a healthier lifespan relative to overall lifespan[5].

The effectiveness of longevity interventions is not uniformly applicable across species. Bene and Salmon (2023) conducted a comparative analysis of pro-longevity interventions in various model organisms and found that while there are many pharmaceutical and small molecule interventions reported to extend lifespan, the translatability of these findings to other species, particularly mice, is limited. Their study highlighted the modest sensitivity and specificity of Drosophila studies in predicting outcomes in mouse lifespan studies, suggesting caution in assuming that findings in one model organism will directly apply to another[46].

Furthermore, Martinović et al. (2024) introduced the concept of the "Longevity Pyramid," which provides a structured framework for understanding the various levels of interventions aimed at extending healthy lifespan. This pyramid emphasizes early detection, lifestyle modifications, and personalized interventions based on individual health profiles. The framework suggests that a combination of these approaches can optimize health outcomes and longevity, underscoring the importance of tailoring strategies to maximize efficacy[47].

The framework for longevity clinics, as proposed by Mironov et al. (2024), further elaborates on innovative healthcare solutions aimed at preventing age-related decline. These clinics focus on "prevention of prevention" through the use of biomarkers and aging clocks, allowing for timely interventions that could extend both lifespan and healthspan[45].

In summary, longevity interventions extend lifespan through a combination of mechanisms that influence healthspan and morbidity. The effectiveness of these interventions can vary significantly across species, and the integration of personalized approaches within a structured framework can enhance their impact. The ongoing research in this field continues to unravel the complexities of aging and the potential for targeted interventions to improve longevity outcomes.

5 Ethical and Societal Implications ​

5.1 Equity in Access to Longevity Interventions ​

Longevity interventions, which encompass a variety of pharmacological, dietary, and genetic strategies, aim to extend lifespan by targeting the biological processes of aging. These interventions often focus on improving metabolic health, enhancing cellular function, and reducing the impact of age-related diseases. For instance, research indicates that reduced growth hormone signaling can increase lifespan in mice by over 50%, while dietary restrictions, such as methionine restriction, have also been shown to extend lifespan in various model organisms [6].

Moreover, the application of these interventions raises significant ethical and societal implications, particularly concerning equity in access. The availability and allocation of life-extending technologies such as resuscitation, mechanical ventilation, and artificial nutrition present critical value issues. These include the equity of access to such technologies, cost-effectiveness, and the legal concerns surrounding their application [48].

Public attitudes towards longevity biotechnology, which aims to extend both healthspan and lifespan, reveal a complex landscape of interest and ambivalence. Studies suggest that while there is considerable interest in the potential benefits of longevity interventions, there are also significant concerns regarding their ethical implications and the societal impact of extended lifespans [49]. The need for equitable access to these interventions is paramount, as disparities in healthcare can exacerbate existing inequalities, leading to a situation where only a subset of the population can benefit from advancements in longevity medicine.

Furthermore, the ethical considerations surrounding the implementation of longevity interventions necessitate a broader public dialogue. Stakeholders in the field of longevity biotechnology are encouraged to engage with the public to understand unmet health needs rather than assuming a universal desire for lifespan extension. This approach not only fosters credibility and trust but also ensures that the promises of longevity interventions are grounded in current scientific evidence and tempered by feasibility [49].

In summary, while longevity interventions have the potential to extend lifespan through various mechanisms, the ethical and societal implications of these technologies, particularly concerning equity in access, must be carefully considered. Addressing these concerns is crucial for fostering an inclusive conversation about the future of longevity medicine and ensuring that its benefits are accessible to all segments of society.

5.2 Impacts on Healthcare Systems ​

Longevity interventions have garnered significant attention in recent years, as research continues to elucidate their mechanisms and potential impacts on lifespan extension. Various studies have demonstrated that interventions can effectively modulate the biological pathways associated with aging, leading to increased lifespan in model organisms and, potentially, in humans.

One of the primary mechanisms through which longevity interventions extend lifespan involves the modulation of the growth hormone (GH)/insulin-like growth factor-1 (IGF-1) axis. Research indicates that reducing GH/IGF-1 signaling, particularly during adulthood, can lead to a substantial increase in lifespan, with findings suggesting that such reductions preferentially benefit females (Duran-Ortiz et al., 2021) [1]. Additionally, dietary interventions, such as those explored in the National Institute of Aging's Intervention Testing Program, have shown that pharmacological agents like rapamycin can positively influence the IGF-1/insulin pathway and extend lifespan in female mice, while other dietary compounds may be effective only in males, highlighting the complexity of sex-specific responses to longevity interventions.

Another critical aspect of longevity interventions is the concept of mitochondrial hormesis or mitohormesis, which posits that increased reactive oxygen species (ROS) formation can serve as a signal for enhanced stress resistance and longevity. Interventions that promote oxidative stress, such as caloric restriction and physical exercise, have been shown to activate mitochondrial functions that contribute to longevity, countering the traditional view that ROS are merely harmful (Ristow & Schmeisser, 2011) [50].

Moreover, interventions such as caloric restriction and exercise not only extend lifespan but also enhance healthspan, which refers to the period of life spent in good health. These interventions have been linked to improved metabolic health, mitochondrial function, and stress resistance, all of which are crucial for delaying age-related diseases (Huffman et al., 2016) [7].

The implications of these findings extend beyond individual health to broader societal and healthcare system considerations. As the global population ages, with projections indicating a rise to 2.1 billion elderly individuals by 2050, the burden on healthcare systems will increase significantly. A focus on extending healthspan rather than merely lifespan can lead to reduced morbidity and disability among older adults, thereby alleviating some of the pressure on healthcare resources (Jugran, 2025) [51].

The concept of the "Longevity Pyramid" introduces a structured approach to longevity medicine, emphasizing early detection and personalized interventions that can optimize health outcomes and potentially extend both lifespan and healthspan (Martinović et al., 2024) [47]. By prioritizing preventive measures and health-promoting behaviors, healthcare systems can shift from reactive to proactive strategies, ultimately improving population health and reducing the economic burden associated with aging.

In summary, longevity interventions extend lifespan through a variety of mechanisms, including modulation of hormonal pathways, activation of stress response systems, and lifestyle modifications. The societal implications of these interventions are profound, as they hold the potential to transform healthcare systems by emphasizing healthspan enhancement, ultimately contributing to healthier aging and reduced healthcare costs.

5.3 Philosophical Considerations of Extended Lifespan ​

The knowledge base information is insufficient. Please consider switching to a different knowledge base or supplementing relevant literature.

6 Future Directions in Longevity Research ​

6.1 Emerging Technologies ​

Longevity interventions are diverse strategies aimed at extending lifespan and promoting healthy aging. These interventions can be broadly categorized into genetic, pharmacological, and dietary approaches, each targeting various biological pathways associated with aging.

Genetic interventions have demonstrated the potential to increase longevity in model organisms by manipulating key signaling pathways, particularly those related to insulin/IGF-1 signaling, caloric intake, and stress resistance. For instance, reduced growth hormone signaling has been shown to increase lifespan in mice by over 50% (Brown-Borg 2016). This approach, however, faces challenges in human application due to the complexities of genetic modifications and their potential effects on other physiological processes.

Pharmacological interventions also play a crucial role in lifespan extension. Various compounds have been identified that can influence longevity through distinct mechanisms. For example, the study by Tyshkovskiy et al. (2023) highlighted that interventions such as KU0063794 can extend lifespan and healthspan in mice by modulating gene expression related to mitochondrial function and metabolism. Additionally, pharmacological agents like rapamycin have been shown to affect the IGF-1/insulin pathway, which preferentially extends lifespan in female mice (Duran-Ortiz et al. 2021).

Dietary interventions, particularly caloric restriction (CR) and intermittent fasting (IF), have garnered significant attention for their role in promoting longevity. CR has been consistently associated with lifespan extension across multiple species by reducing oxidative stress and enhancing metabolic health (Hwangbo et al. 2020). IF, as an alternative to continuous caloric restriction, has been shown to activate similar pathways that promote longevity, including the target of rapamycin (TOR) pathway and circadian rhythms (Hwangbo et al. 2020). These dietary strategies not only extend lifespan but also improve healthspan by delaying the onset of age-related diseases.

Emerging technologies in longevity research are focused on understanding the underlying mechanisms of aging and the potential for novel interventions. For instance, advancements in gene expression analysis, such as RNA sequencing, have facilitated the identification of longevity signatures that can guide the development of new therapeutic candidates (Tyshkovskiy et al. 2019). Moreover, the concept of the "Longevity Pyramid" emphasizes a structured approach to longevity medicine, incorporating early detection, lifestyle modifications, and personalized interventions tailored to individual health profiles (Martinović et al. 2024).

The future of longevity research will likely see a combination of these interventions, leveraging insights from genetic, pharmacological, and dietary studies to develop comprehensive strategies for extending lifespan and healthspan. This integrative approach may not only enhance our understanding of the biology of aging but also lead to practical applications that can mitigate age-related diseases and improve quality of life for aging populations.

In summary, longevity interventions extend lifespan through a multifaceted approach that includes genetic manipulation, pharmacological agents, and dietary modifications, all targeting various pathways associated with aging. The ongoing exploration of these strategies, combined with emerging technologies, holds promise for advancing our understanding of longevity and developing effective interventions.

6.2 Personalized Medicine Approaches ​

Longevity interventions extend lifespan through various mechanisms that target fundamental biological processes associated with aging. These interventions encompass a range of strategies, including dietary modifications, pharmacological treatments, and genetic manipulations, all aimed at mitigating the effects of aging and promoting healthspan.

One significant area of focus in longevity research is the modulation of metabolic pathways. For instance, the growth hormone (GH)/insulin-like growth factor-1 (IGF-1) axis has been shown to play a critical role in aging. Reductions in GH signaling have been associated with lifespan extension in mice, with studies indicating an increase in lifespan by over 50% through such interventions (Brown-Borg 2016). Similarly, dietary interventions, such as methionine restriction, have demonstrated the ability to extend lifespan in various model organisms by improving metabolic health and enhancing resistance to stressors (Brown-Borg 2016).

Caloric restriction (CR) and intermittent fasting (IF) are two dietary strategies that have garnered attention for their potential to extend lifespan. CR involves reducing calorie intake without compromising nutritional value, while IF restricts food intake to specific time windows. Both strategies have been shown to activate cellular pathways that promote longevity, such as the target of rapamycin (TOR) pathway and the circadian clock (Hwangbo et al. 2020). These dietary manipulations can induce metabolic changes that reduce oxidative stress and inflammation, which are key contributors to aging.

Furthermore, recent advancements in personalized medicine approaches emphasize the importance of tailoring interventions based on individual genetic and lifestyle factors. The concept of the "Longevity Pyramid" outlines a structured framework for understanding diverse strategies in longevity medicine, from preventive measures and lifestyle modifications to personalized interventions based on genetic predispositions (Martinović et al. 2024). This approach aims to optimize the efficacy of interventions by aligning them with an individual's unique health profile.

The integration of geroscience into clinical practice is another promising direction in longevity research. By leveraging biomarker tracking and metabolic therapies, researchers are beginning to redefine aging as a modifiable process, allowing for targeted strategies that delay aging and enhance both lifespan and healthspan (Boccardi 2025). This shift towards an integrated longevity medicine model holds the potential to address age-related diseases more effectively by focusing on the underlying mechanisms of aging rather than treating individual conditions in isolation.

Additionally, the exploration of cellular senescence and the development of senolytic therapies are gaining traction as viable interventions for promoting longevity. Senolytics target and eliminate senescent cells, which accumulate with age and contribute to chronic inflammation and tissue dysfunction (Tchkonia et al. 2021). By addressing the root causes of aging at the cellular level, these therapies may significantly extend healthspan and lifespan.

In conclusion, longevity interventions extend lifespan through a multifaceted approach that includes dietary modifications, metabolic interventions, and personalized medicine strategies. The future of longevity research is likely to focus on the integration of these various approaches, emphasizing the need for a comprehensive understanding of aging mechanisms and the development of tailored interventions to enhance health and longevity across diverse populations.

6.3 Integration of Interventions for Optimal Outcomes ​

Longevity interventions have been a focal point in aging research, with numerous studies exploring various methods to extend lifespan and healthspan. The mechanisms by which these interventions operate are diverse and often interconnected, focusing on metabolic pathways, gene expression changes, and environmental factors.

One prominent area of investigation is the modulation of the growth hormone (GH) and insulin-like growth factor-1 (IGF-1) axis. Research has shown that reduced GH signaling can lead to significant lifespan extension in mice, with increases of over 50% reported (Brown-Borg 2016). This intervention is particularly effective when applied at different life stages, highlighting its potential for enhancing healthy aging in both male and female subjects (Duran-Ortiz et al. 2021).

Caloric restriction (CR) is another well-documented intervention that promotes longevity. CR not only extends lifespan but also improves healthspan by delaying the onset of age-related diseases. It is suggested that CR operates through the activation of mitochondrial oxygen consumption, which increases the formation of reactive oxygen species (ROS). These ROS act as signaling molecules that trigger adaptive stress responses, thereby enhancing longevity (Ristow and Schmeisser 2011). However, it is essential to note that the health benefits of CR can be compromised by antioxidant supplements that inhibit ROS signaling, thus interfering with the beneficial effects of CR and physical exercise (Ristow and Schmeisser 2011).

Pharmacological interventions also play a crucial role in extending lifespan. For instance, compounds such as rapamycin and metformin have been shown to target the IGF-1 signaling pathway and improve metabolic health (Duran-Ortiz et al. 2021). These drugs can extend lifespan in various model organisms, including mice, by enhancing stress resistance and metabolic function. Moreover, a recent study identified gene expression signatures associated with lifespan extension across multiple interventions, underscoring the potential for pharmacological approaches to promote longevity through shared biological pathways (Tyshkovskiy et al. 2019).

The integration of multiple interventions has been proposed as a strategy to optimize outcomes in longevity research. By combining interventions that target non-overlapping pathways, researchers aim to achieve synergistic effects that could lead to greater improvements in both lifespan and healthspan (Duran-Ortiz et al. 2021). This approach recognizes the complexity of aging and the need for a multifaceted strategy to address the various biological processes involved.

Furthermore, ongoing research into the genetic basis of longevity is essential for identifying new interventions. The LongevityMap database serves as a resource for understanding the genetic variants associated with longevity in humans, which could inform future therapeutic strategies (Budovsky et al. 2013). Additionally, studies examining the interactions between different longevity interventions are crucial for understanding how these strategies can be effectively combined to maximize their benefits (Nowak et al. 2018).

In summary, longevity interventions extend lifespan through a combination of metabolic modulation, gene expression changes, and the strategic integration of various approaches. Future research directions should focus on refining these interventions, understanding their interactions, and exploring genetic factors that influence longevity to develop comprehensive strategies for promoting healthy aging.

7 Conclusion ​

The exploration of longevity interventions reveals a multifaceted approach to extending lifespan and enhancing healthspan. Key findings underscore the significance of targeting biological mechanisms such as cellular senescence, oxidative stress, and chronic inflammation. The current research landscape showcases a diverse array of interventions, including caloric restriction, pharmacological agents like rapamycin and metformin, genetic modifications through CRISPR technology, and lifestyle changes that encompass diet and exercise. These strategies not only aim to prolong lifespan but also focus on improving the quality of life by mitigating age-related diseases. However, the effectiveness of these interventions can vary significantly across different species, highlighting the need for careful translation of findings from preclinical models to human applications. Future research should emphasize personalized medicine approaches, integrating various interventions to optimize outcomes while addressing ethical and societal implications related to equitable access to longevity technologies. As the global population ages, the development of comprehensive strategies that promote healthy aging will be crucial in alleviating the burden on healthcare systems and enhancing the overall quality of life for aging populations.

References ​

  • [1] Silvana Duran-Ortiz;Edward O List;Reetobrata Basu;John J Kopchick. Extending lifespan by modulating the growth hormone/insulin-like growth factor-1 axis: coming of age.. Pituitary(IF=3.4). 2021. PMID:33459974. DOI: 10.1007/s11102-020-01117-0.
  • [2] Alexander Tyshkovskiy;Siming Ma;Anastasia V Shindyapina;Stanislav Tikhonov;Sang-Goo Lee;Perinur Bozaykut;José P Castro;Andrei Seluanov;Nicholas J Schork;Vera Gorbunova;Sergey E Dmitriev;Richard A Miller;Vadim N Gladyshev. Distinct longevity mechanisms across and within species and their association with aging.. Cell(IF=42.5). 2023. PMID:37269831. DOI: 10.1016/j.cell.2023.05.002.
  • [3] Piotr Paweł Chmielewski;Krzysztof Data;Bartłomiej Strzelec;Maryam Farzaneh;Amir Anbiyaiee;Uzma Zaheer;Shahab Uddin;Mohadeseh Sheykhi-Sabzehpoush;Paul Mozdziak;Maciej Zabel;Piotr Dzięgiel;Bartosz Kempisty. Human Aging and Age-Related Diseases: From Underlying Mechanisms to Pro-Longevity Interventions.. Aging and disease(IF=6.9). 2024. PMID:38913049. DOI: 10.14336/AD.2024.0280.
  • [4] Dae-Sung Hwangbo;Hye-Yeon Lee;Leen Suleiman Abozaid;Kyung-Jin Min. Mechanisms of Lifespan Regulation by Calorie Restriction and Intermittent Fasting in Model Organisms.. Nutrients(IF=5.0). 2020. PMID:32344591. DOI: 10.3390/nu12041194.
  • [5] Yifan Yang;Avi Mayo;Tomer Levy;Naveh Raz;Ben Shenhar;Daniel F Jarosz;Uri Alon. Compression of morbidity by interventions that steepen the survival curve.. Nature communications(IF=15.7). 2025. PMID:40199852. DOI: 10.1038/s41467-025-57807-5.
  • [6] Holly M Brown-Borg. Reduced growth hormone signaling and methionine restriction: interventions that improve metabolic health and extend life span.. Annals of the New York Academy of Sciences(IF=4.8). 2016. PMID:26645136. DOI: 10.1111/nyas.12971.
  • [7] Derek M Huffman;Marissa J Schafer;Nathan K LeBrasseur. Energetic interventions for healthspan and resiliency with aging.. Experimental gerontology(IF=4.3). 2016. PMID:27260561. DOI: 10.1016/j.exger.2016.05.012.
  • [8] Andrey A Parkhitko;Elizabeth Filine;Marc Tatar. Combinatorial interventions in aging.. Nature aging(IF=19.4). 2023. PMID:37783817. DOI: 10.1038/s43587-023-00489-9.
  • [9] Tamar Tchkonia;Allyson K Palmer;James L Kirkland. New Horizons: Novel Approaches to Enhance Healthspan Through Targeting Cellular Senescence and Related Aging Mechanisms.. The Journal of clinical endocrinology and metabolism(IF=5.1). 2021. PMID:33155651. DOI: 10.1210/clinem/dgaa728.
  • [10] S I S Rattan;R Singh. Progress & prospects: gene therapy in aging.. Gene therapy(IF=4.5). 2009. PMID:19005494. DOI: 10.1038/gt.2008.166.
  • [11] Jinxue Liu;Hongliang Yu;Yuanyuan Xu. Targeting Cellular Senescence: Pathophysiology in Multisystem Age-Related Diseases.. Biomedicines(IF=3.9). 2025. PMID:40722797. DOI: 10.3390/biomedicines13071727.
  • [12] Virginia Boccardi;Miranda Ethel Orr;M Cristina Polidori;Carmelinda Ruggiero;Patrizia Mecocci. Focus on senescence: Clinical significance and practical applications.. Journal of internal medicine(IF=9.2). 2024. PMID:38446642. DOI: 10.1111/joim.13775.
  • [13] Esther Ugo Alum;Sylvester Chibueze Izah;Daniel Ejim Uti;Okechukwu Paul-Chima Ugwu;Peter A Betiang;Mariam Basajja;Regina Idu Ejemot-Nwadiaro. Targeting Cellular Senescence for Healthy Aging: Advances in Senolytics and Senomorphics.. Drug design, development and therapy(IF=5.1). 2025. PMID:40994903. DOI: 10.2147/DDDT.S543211.
  • [14] Begun Erbaba;Ayca Arslan-Ergul;Michelle M Adams. Effects of caloric restriction on the antagonistic and integrative hallmarks of aging.. Ageing research reviews(IF=12.4). 2021. PMID:33246078. DOI: 10.1016/j.arr.2020.101228.
  • [15] Li He;Donglei Han;Fenfen Zong;Yan Zhang;Zhongyang Han;Zenghui Xu. Recent progress in stem cell and immune cell-based interventions for aging and age-related disorders.. Frontiers in aging(IF=4.3). 2025. PMID:40765725. DOI: 10.3389/fragi.2025.1638168.
  • [16] Reinald Pamplona;Gustavo Barja. An evolutionary comparative scan for longevity-related oxidative stress resistance mechanisms in homeotherms.. Biogerontology(IF=4.1). 2011. PMID:21755337. DOI: 10.1007/s10522-011-9348-1.
  • [17] David E Shore;Gary Ruvkun. A cytoprotective perspective on longevity regulation.. Trends in cell biology(IF=18.1). 2013. PMID:23726168. DOI: .
  • [18] Ana Mesquita;Martin Weinberger;Alexandra Silva;Belém Sampaio-Marques;Bruno Almeida;Cecília Leão;Vítor Costa;Fernando Rodrigues;William C Burhans;Paula Ludovico. Caloric restriction or catalase inactivation extends yeast chronological lifespan by inducing H2O2 and superoxide dismutase activity.. Proceedings of the National Academy of Sciences of the United States of America(IF=9.1). 2010. PMID:20696905. DOI: 10.1073/pnas.1004432107.
  • [19] Serena Dato;Paolina Crocco;Patrizia D'Aquila;Francesco de Rango;Dina Bellizzi;Giuseppina Rose;Giuseppe Passarino. Exploring the role of genetic variability and lifestyle in oxidative stress response for healthy aging and longevity.. International journal of molecular sciences(IF=4.9). 2013. PMID:23965963. DOI: 10.3390/ijms140816443.
  • [20] Emma S Chambers;Arne N Akbar. Can blocking inflammation enhance immunity during aging?. The Journal of allergy and clinical immunology(IF=11.2). 2020. PMID:32386656. DOI: 10.1016/j.jaci.2020.03.016.
  • [21] Rafael Cardoso Maciel Costa Silva. The dichotomic role of cytokines in aging.. Biogerontology(IF=4.1). 2024. PMID:39621124. DOI: 10.1007/s10522-024-10152-4.
  • [22] Ben Dugan;Jessica Conway;Niharika A Duggal. Inflammaging as a target for healthy ageing.. Age and ageing(IF=7.1). 2023. PMID:36735849. DOI: 10.1093/ageing/afac328.
  • [23] Ricardo Gredilla;Gustavo Barja. Minireview: the role of oxidative stress in relation to caloric restriction and longevity.. Endocrinology(IF=3.3). 2005. PMID:15919745. DOI: 10.1210/en.2005-0378.
  • [24] Chiara Ruocco;Maurizio Ragni;Enzo Nisoli. The heat of longevity: sex differences in lifespan and body temperature.. Frontiers in pharmacology(IF=4.8). 2024. PMID:39654619. DOI: 10.3389/fphar.2024.1512526.
  • [25] Andrea Di Francesco;Andrew G Deighan;Lev Litichevskiy;Zhenghao Chen;Alison Luciano;Laura Robinson;Gaven Garland;Hannah Donato;Matthew Vincent;Will Schott;Kevin M Wright;Anil Raj;G V Prateek;Martin Mullis;Warren G Hill;Mark L Zeidel;Luanne L Peters;Fiona Harding;David Botstein;Ron Korstanje;Christoph A Thaiss;Adam Freund;Gary A Churchill. Dietary restriction impacts health and lifespan of genetically diverse mice.. Nature(IF=48.5). 2024. PMID:39385029. DOI: 10.1038/s41586-024-08026-3.
  • [26] Victoria Acosta-Rodríguez;Filipa Rijo-Ferreira;Mariko Izumo;Pin Xu;Mary Wight-Carter;Carla B Green;Joseph S Takahashi. Circadian alignment of early onset caloric restriction promotes longevity in male C57BL/6J mice.. Science (New York, N.Y.)(IF=45.8). 2022. PMID:35511946. DOI: 10.1126/science.abk0297.
  • [27] Emily W Flanagan;Jasper Most;Jacob T Mey;Leanne M Redman. Calorie Restriction and Aging in Humans.. Annual review of nutrition(IF=13.4). 2020. PMID:32559388. DOI: 10.1146/annurev-nutr-122319-034601.
  • [28] Amie J Dirks;Christiaan Leeuwenburgh. Caloric restriction in humans: potential pitfalls and health concerns.. Mechanisms of ageing and development(IF=5.1). 2006. PMID:16226298. DOI: 10.1016/j.mad.2005.09.001.
  • [29] Edward R Ivimey-Cook;Zahida Sultanova;Alexei A Maklakov. Rapamycin, Not Metformin, Mirrors Dietary Restriction-Driven Lifespan Extension in Vertebrates: A Meta-Analysis.. Aging cell(IF=7.1). 2025. PMID:40532901. DOI: 10.1111/acel.70131.
  • [30] Jie Chen;Yuhui Ou;Yi Li;Shumei Hu;Li-Wa Shao;Ying Liu. Metformin extends C. elegans lifespan through lysosomal pathway.. eLife(IF=6.4). 2017. PMID:29027899. DOI: .
  • [31] Yi Xiao;Fang Liu;Qinghong Kong;Xinting Zhu;Haijuan Wang;Sanhua Li;Nian Jiang;Changyan Yu;Liu Yun. Metformin induces S-adenosylmethionine restriction to extend the Caenorhabditis elegans healthspan through H3K4me3 modifiers.. Aging cell(IF=7.1). 2022. PMID:35146893. DOI: 10.1111/acel.13567.
  • [32] Jingqi Fang;Jiping Yang;Xun Wu;Gangming Zhang;Tao Li;Xi'e Wang;Hong Zhang;Chih-Chen Wang;Guang-Hui Liu;Lei Wang. Metformin alleviates human cellular aging by upregulating the endoplasmic reticulum glutathione peroxidase 7.. Aging cell(IF=7.1). 2018. PMID:29659168. DOI: 10.1111/acel.12765.
  • [33] Yi A Chen;Mark W Kankel;Sam Hana;Shukkwan Kelly Lau;Maria I Zavodszky;Olivia McKissick;Nicole Mastrangelo;Jessica Dion;Bin Wang;Daniel Ferretti;David Koske;Sydney Lehman;Kathryn Koszka;Helen McLaughlin;Mei Liu;Eric Marshall;Attila J Fabian;Patrick Cullen;Galina Marsh;Stefan Hamann;Michael Craft;Jennifer Sebalusky;H Moore Arnold;Rachelle Driscoll;Adam Sheehy;Yi Luo;Sonia Manca;Thomas Carlile;Chao Sun;Kirsten Sigrist;Alexander McCampbell;Christopher E Henderson;Shih-Ching Lo. In vivo genome editing using novel AAV-PHP variants rescues motor function deficits and extends survival in a SOD1-ALS mouse model.. Gene therapy(IF=4.5). 2023. PMID:36450833. DOI: 10.1038/s41434-022-00375-w.
  • [34] Alexander Tyshkovskiy;Perinur Bozaykut;Anastasia A Borodinova;Maxim V Gerashchenko;Gene P Ables;Michael Garratt;Philipp Khaitovich;Clary B Clish;Richard A Miller;Vadim N Gladyshev. Identification and Application of Gene Expression Signatures Associated with Lifespan Extension.. Cell metabolism(IF=30.9). 2019. PMID:31353263. DOI: 10.1016/j.cmet.2019.06.018.
  • [35] Lorna Mulvey;Amy Sinclair;Colin Selman. Lifespan modulation in mice and the confounding effects of genetic background.. Journal of genetics and genomics = Yi chuan xue bao(IF=7.1). 2014. PMID:25269675. DOI: .
  • [36] Clea Bárcena;Pedro M Quirós;Sylvère Durand;Pablo Mayoral;Francisco Rodríguez;Xurde M Caravia;Guillermo Mariño;Cecilia Garabaya;María Teresa Fernández-García;Guido Kroemer;José M P Freije;Carlos López-Otín. Methionine Restriction Extends Lifespan in Progeroid Mice and Alters Lipid and Bile Acid Metabolism.. Cell reports(IF=6.9). 2018. PMID:30157432. DOI: 10.1016/j.celrep.2018.07.089.
  • [37] Bente Klarlund Pedersen. Which type of exercise keeps you young?. Current opinion in clinical nutrition and metabolic care(IF=3.5). 2019. PMID:30640736. DOI: 10.1097/MCO.0000000000000546.
  • [38] T Brown;A Avenell;L D Edmunds;H Moore;V Whittaker;L Avery;C Summerbell. Systematic review of long-term lifestyle interventions to prevent weight gain and morbidity in adults.. Obesity reviews : an official journal of the International Association for the Study of Obesity(IF=7.4). 2009. PMID:19754634. DOI: 10.1111/j.1467-789X.2009.00641.x.
  • [39] Marjorie Buttet;Reza Bagheri;Ukadike C Ugbolue;Catherine Laporte;Marion Trousselard;Amanda Benson;Jean-Baptiste Bouillon-Minois;Frédéric Dutheil. Effect of a lifestyle intervention on telomere length: A systematic review and meta-analysis.. Mechanisms of ageing and development(IF=5.1). 2022. PMID:35760212. DOI: 10.1016/j.mad.2022.111694.
  • [40] M A Lane;A Black;A Handy;E M Tilmont;D K Ingram;G S Roth. Caloric restriction in primates.. Annals of the New York Academy of Sciences(IF=4.8). 2001. PMID:11795520. DOI: 10.1111/j.1749-6632.2001.tb05658.x.
  • [41] Peter Stenvinkel;Jeroen P Kooman;Paul G Shiels. Nutrients and ageing: what can we learn about ageing interactions from animal biology?. Current opinion in clinical nutrition and metabolic care(IF=3.5). 2016. PMID:26485336. DOI: 10.1097/MCO.0000000000000234.
  • [42] Yaning Sun;Jason Yolitz;Thomas Alberico;Xiaoping Sun;Sige Zou. Lifespan extension by cranberry supplementation partially requires SOD2 and is life stage independent.. Experimental gerontology(IF=4.3). 2014. PMID:24316039. DOI: .
  • [43] James L Kirkland. Translating advances from the basic biology of aging into clinical application.. Experimental gerontology(IF=4.3). 2013. PMID:23237984. DOI: .
  • [44] Yasmine J Liu;Rebecca L McIntyre;Georges E Janssens. Considerations Regarding Public Use of Longevity Interventions.. Frontiers in aging(IF=4.3). 2022. PMID:35821857. DOI: 10.3389/fragi.2022.903049.
  • [45] Sergey Mironov;Olga Borysova;Ivan Morgunov;Zhongjun Zhou;Alexey Moskalev. A Framework for an Effective Healthy Longevity Clinic.. Aging and disease(IF=6.9). 2024. PMID:38607731. DOI: 10.14336/AD.2024.0328-1.
  • [46] Michael Bene;Adam B Salmon. Testing the evidence that lifespan-extending compound interventions are conserved across laboratory animal model species.. GeroScience(IF=5.4). 2023. PMID:36637786. DOI: 10.1007/s11357-022-00722-0.
  • [47] Anđela Martinović;Matilde Mantovani;Natalia Trpchevska;Eva Novak;Nikolay B Milev;Leonie Bode;Collin Y Ewald;Evelyne Bischof;Tobias Reichmuth;Rebecca Lapides;Alexander Navarini;Babak Saravi;Elisabeth Roider. Climbing the longevity pyramid: overview of evidence-driven healthcare prevention strategies for human longevity.. Frontiers in aging(IF=4.3). 2024. PMID:39659760. DOI: 10.3389/fragi.2024.1495029.
  • [48] M B Kapp. Life-sustaining technologies: value issues.. The Journal of social issues(IF=4.7). 1993. PMID:17167919. DOI: 10.1111/j.1540-4560.1993.tb00925.x.
  • [49] Alberto Aparicio. Public alignment with longevity biotechnology: an analysis of framing in surveys and opinion studies.. Biogerontology(IF=4.1). 2024. PMID:39585500. DOI: 10.1007/s10522-024-10157-z.
  • [50] Michael Ristow;Sebastian Schmeisser. Extending life span by increasing oxidative stress.. Free radical biology & medicine(IF=8.2). 2011. PMID:21619928. DOI: 10.1016/j.freeradbiomed.2011.05.010.
  • [51] Deepak Jugran. Too well to die; too ill to live: an update on the lifespan versus health span debate.. Journal of global health(IF=4.3). 2025. PMID:40353717. DOI: 10.7189/jogh.15.03022.

MaltSci Intelligent Research Services ​

Search for more papers on MaltSci.com ​

longevity interventions · biological mechanisms · cellular senescence · oxidative stress · healthspan

© 2025 MaltSci